Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
Contact US
Breakthrough T1d, Formerly Jdrf
Drug Discovery & Development
Overview
Contact US
Contributions
Contributors
Contributions
0 Contributors
1 / 0
1 / 0
1 Contributions
1 / 1
1 / 1
No authors found
Financing
Statement from Aaron J. Kowalski, the Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts
Breakthrough T1d, Formerly Jdrf
PR-02-25-NI-10
Feb 11, 2025
